Infectious complications of the hemodialysis access

Bloembergen, 1996, Epidemiological perspective on infections in chronic dialysis patients, Adv Ren Replace Ther, 3, 201, 10.1016/S1073-4449(96)80022-7 1997, Causes of death: USRDS: United States Renal Data System, Am J Kidney Dis, 30, S107 Mailloux, 1991, Mortality in dialysis patients: Analysis of the causes of death, Am J Kidney Dis, 18, 326, 10.1016/S0272-6386(12)80091-6 Zander, 1989, Causes of death in insulin-dependent diabetic patients treated with hemodialysis, J Diabetes Complications, 3, 163, 10.1016/0891-6632(89)90040-8 Sarnak, 2000, Mortality caused by sepsis in patients with end-stage renal disease compared with the general population, Kidney Int, 58, 1758, 10.1111/j.1523-1755.2000.00337.x Churchill, 1992, Canadian Hemodialysis Morbidity Study, Am J Kidney Dis, 19, 214, 10.1016/S0272-6386(13)80002-9 Powe, 1999, Septicemia in dialysis patients: Incidence, risk factors, and prognosis, Kidney Int, 55, 1081, 10.1046/j.1523-1755.1999.0550031081.x Kessler, 1993, Bacteremia in patients on chronic hemodialysis: A multicenter prospective survey, Nephron, 64, 95, 10.1159/000187285 Marr Ka, 1998, Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients, Kidney Int, 54, 1684, 10.1046/j.1523-1755.1998.00134.x Quarles, 1985, Staphylococcus aureus bacteremia in patients on chronic hemodialysis, Am J Kidney Dis, 6, 412, 10.1016/S0272-6386(85)80104-9 Zaleski, 1999, Experience with tunneled femoral hemodialysis catheters, Am J Roentgenol, 172, 493, 10.2214/ajr.172.2.9930810 Nielsen, 1998, Dialysis catheter-related septicaemia: Focus on Staphylococcus aureus septicaemia, Nephrol Dial Transplant, 13, 2847, 10.1093/ndt/13.11.2847 Dobkin, 1978, Septicemia in patients on chronic hemodialysis, Ann Intern Med, 88, 28, 10.7326/0003-4819-88-1-28 Robinson, 1997, Bacterial endocarditis in hemodialysis patients, Am J Kidney Dis, 30, 521, 10.1016/S0272-6386(97)90311-5 Obrador, 1996, Spinal epidural abscess in hemodialysis patients: Report of three cases and review of the literature, Am J Kidney Dis, 27, 75, 10.1016/S0272-6386(96)90033-5 Peacock, 1999, Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia, J Hosp Infect, 41, 223, 10.1016/S0195-6701(99)90020-8 Kovalik, 1996, A clustering of cases of spinal epidural abscess in hemodialysis patients, J Am Soc Nephrol, 7, 2264, 10.1681/ASN.V7102264 Kaplowitz, 1988, A prospective study of infections in hemodialysis patients: Patient hygiene and other risk factors for infection, Infect Control Hosp Epidemiol, 9, 534, 10.2307/30144191 Bonomo, 1997, Risk factors associated with permanent access-site infections in chronic hemodialysis patients, Infect Control Hosp Epidemiol, 18, 757, 10.2307/30141318 Hoen, 1998, EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients, J Am Soc Nephrol, 9, 869, 10.1681/ASN.V95869 Kairaitis, 1999, Outcome and complications of temporary haemodialysis catheters, Nephrol Dial Transplant, 14, 1704, 10.1093/ndt/14.7.1710 Connoly, 1984, Complications of renal dialysis access procedures, Arch Surg, 119, 1325, 10.1001/archsurg.1984.01390230091023 Munda, 1983, Polytetrafluoroethylene graft survival in hemodialysis, JAMA, 249, 219, 10.1001/jama.1983.03330260037028 Schwab, 1999, The hemodialysis catheter conundrum: Hate living with them, but can't live without them, Kidney Int, 56, 1, 10.1046/j.1523-1755.1999.00512.x Tokars, 1998, National surveillance of dialysis associated diseases in the United States, 1995, ASAIO J, 44, 98, 10.1097/00002480-199801000-00019 Hung, 1995, Infection associated with double lumen catheterization for temporary haemodialysis: Experience of 168 cases, Nephrol Dial Transplant, 10, 247 Schwab, 1988, Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use, Am J Kidney Dis, 11, 166, 10.1016/S0272-6386(88)80206-3 Moss, 1990, Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients, Am J Kidney Dis, 16, 211, 10.1016/S0272-6386(12)81020-1 Marr, 1997, Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis, Ann Intern Med, 127, 275, 10.7326/0003-4819-127-4-199708150-00003 Beathard, 1999, Management of bacteremia associated with tunneled-cuffed hemodialysis catheters, J Am Soc Nephrol, 10, 1045, 10.1681/ASN.V1051045 Saad, 1999, Bacteremia associated with tunneled, cuffed hemodialysis catheters, Am J Kidney Dis, 34, 1114, 10.1016/S0272-6386(99)70018-1 Dittmer, 1999, A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia, Clin Nephrol, 51, 34 Boelaert, 1993, Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients, Nephrol Dial Transplant, 8, 235 Boelaert, 1991, The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: An analysis of cost-effectiveness, J Hosp Infect, 19, 41, 10.1016/0195-6701(91)90202-J Boelaert, 1996, Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: The effect of nasal mupirocin, Infect Control Hosp Epidemiol, 17, 809, 10.2307/30141175 Tanriover, 2000, Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies, Kidney Int, 57, 2151, 10.1046/j.1523-1755.2000.00067.x Passerini, 1992, Biofilms on indwelling vascular catheters, Crit Care Med, 20, 665, 10.1097/00003246-199205000-00020 Vercaigne, 2000, Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter, Pharmacotherapy, 20, 394, 10.1592/phco.20.5.394.35063 Maki, 1998, Attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial, Am J Med, 85, 307, 10.1016/0002-9343(88)90579-7 Maki, 1997, Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial, Ann Intern Med, 127, 257, 10.7326/0003-4819-127-4-199708150-00001 Raad, 1995, Antibiotics and prevention of microbial colonization of catheters, Antimicrob Agents Chemother, 39, 2397, 10.1128/AAC.39.11.2397 Raad, 1996, The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin, J Infect Dis, 173, 418, 10.1093/infdis/173.2.418 Darouiche, 1999, A comparison of two antimicrobial-impregnated central venous catheters, N Engl J Med, 340, 1, 10.1056/NEJM199901073400101 Levin, 1998, Initial results of a new access device for hemodialysis, Kidney Int, 54, 1739, 10.1046/j.1523-1755.1998.00128.x Canaud, 1999, Dialock: Pilot trial of a new vascular port access device for hemodialysis, Semin Dial, 12, 382, 10.1046/j.1525-139X.1999.99060.x Canaud, 1999, Dialock: A new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical results, Nephrol Dial Transplant, 14, 692, 10.1093/ndt/14.3.692 Fong, 1993, Infection of arterio-venous fistulas created for chronic haemodialysis, Scand J Infect Dis, 25, 215, 10.3109/00365549309008487 Taylor, 1996, Results and complications of arteriovenous access dialysis grafts in the lower extremity: A five year review, Am Surg, 62, 188 Zibari, 1997, Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections, Am J Kidney Dis, 30, 343, 10.1016/S0272-6386(97)90277-8 Raju, 1987, PTFE grafts for hemodialysis access: Techniques for insertion manage complications, Ann Surg, 206, 666, 10.1097/00000658-198711000-00019 Curi, 1999, Hemodialysis access: Influence of the human immunodeficiency virus on patency and infection rates, J Vasc Surg, 29, 608, 10.1016/S0741-5214(99)70305-8 Alpers, 1996, Clinical considerations in hemodialysis access infection, Adv Ren Replace Ther, 3, 208, 10.1016/S1073-4449(96)80023-9 Fowler, 1999, Recurrent Staphylococcus aureus bacteremia: Pulsed-field gel electrophoresis findings in 29 patients, J Infect Dis, 179, 1157, 10.1086/314712 Bosman, 1998, A comparison between PTFE and denatured homologous vein grafts for haemodialysis access: A prospective randomized multicentre trial. The SMASH study group. Study of graft materials in access for haemodialysis, Eur J Vasc Endovasc Surg, 16, 126, 10.1016/S1078-5884(98)80153-6 Ayus, 1998, Silent infection in clotted hemodialysis access grafts, J Am Soc Nephrol, 9, 1314, 10.1681/ASN.V971314 Sheikh-Hamad, 1998, The patient with a clotted PTFE graft developing fever, Nephrol Dial Transplant, 13, 2392, 10.1093/ndt/13.9.2392 Nassar, 2000, Clotted arteriovenous grafts: A silent source of infection, Semin Dial, 13, 1, 10.1046/j.1525-139x.2000.00006.x Syrjala, 1987, Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients, J Nucl Med, 28, 155 Schmidt, 1987, Indium-111 granulocyte scintigraphy in the evaluation of patients with fever of undetermined origin, Scand J Infect Dis, 19, 339, 10.3109/00365548709018480 Lawrence, 1985, Indium-111-labeled leukocyte scanning for detection of prosthetic vascular graft infection, J Vasc Surg, 2, 165 Palestro, 1990, Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection, J Nucl Med, 31, 319 McIntyre, 1997, Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients, Clin Nephrol, 48, 371 Haubitz, 1996, Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy, Perit Dial Int, 16, 158, 10.1177/089686089601600213 Nassar, 1999, Choosing antimicrobial therapy for a febrile patient on hemodialysis, J Crit Illness, 9, 8 Uttley, 1989, High-level vancomycin-resistant entercococci causing hospital infections, Epidemiol Infect, 103, 173, 10.1017/S0950268800030478 Shay, 1995, Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections, J Infect Dis, 172, 993, 10.1093/infdis/172.4.993 Singer, 1996, Pseudo-outbreak of enterococcus durans infections and colonization associated with introduction of an automated identification system software update, J Clin Microbiol, 34, 2685, 10.1128/JCM.34.11.2685-2687.1996 Grayson, 1999, Outcome of a screening program for vancomyin-resistant enterococci in a hospital in Victoria, Med J Aust, 171, 133, 10.5694/j.1326-5377.1999.tb123564.x Keane, 1996, Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update, Perit Dial Int, 16, 557, 10.1177/089686089601600606 Centers for Disease Control and Prevention, 1995, Recommendations for preventing the spread of vancomycin resistance, MMWR Morb Mortal Wkly Rep, 44, 1 Fogel, 1998, Cefazolin in chronic hemodialysis patients: A safe and effective alternative to vancomycin, Am J Kidney Dis, 32, 401, 10.1053/ajkd.1998.v32.pm9740155 Marx, 1998, Cefazolin as empiric therapy in hemodialysis-related infections: Efficacy and blood concentrations, Am J Kidney Dis, 32, 410, 10.1053/ajkd.1998.v32.pm9740156 Musher, 1994, The current spectrum of Staphylococcus aureus infection in a tertiary care hospital, Medicine (Baltimore), 73, 186, 10.1097/00005792-199407000-00002 Feldman, 1996, Hemodialysis vascular access morbidity, J Am Soc Nephrol, 7, 523, 10.1681/ASN.V74523